{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:46:19Z","timestamp":1778323579807,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.leukres.2012.10.017","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T09:30:57Z","timestamp":1352712657000},"page":"434-439","source":"Crossref","is-referenced-by-count":45,"title":["Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"Wenqing","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Spier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence S.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel O.","family":"Persky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daruka","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.leukres.2012.10.017_bib0005","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.leukres.2012.10.017_bib0010","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1158\/1078-0432.CCR-09-1995","article-title":"New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies","volume":"16","author":"Dunleavy","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.leukres.2012.10.017_bib0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.23144","article-title":"The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Armitage","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2012.10.017_bib0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/asheducation-2011.1.515","article-title":"Therapies for peripheral T-cell lymphomas","volume":"2011","author":"Savage","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.leukres.2012.10.017_bib0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1586\/ehm.11.55","article-title":"Targeted molecular therapy in peripheral T-cell lymphomas","volume":"4","author":"Roncolato","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"14","key":"10.1016\/j.leukres.2012.10.017_bib0030","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2010.32.7171","article-title":"Novel therapeutics for aggressive non-Hodgkin's lymphoma","volume":"29","author":"Mahadevan","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.leukres.2012.10.017_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/17460441.2011.555395","article-title":"Update on aurora kinase targeted therapeutics in oncology","volume":"6","author":"Green","year":"2011","journal-title":"Expert Opin Drug Discov"},{"issue":"1584","key":"10.1016\/j.leukres.2012.10.017_bib0040","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1098\/rstb.2011.0072","article-title":"Spindle assembly checkpoint: the third decade","volume":"366","author":"Musacchio","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"10.1016\/j.leukres.2012.10.017_bib0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcb.2010.10.007","article-title":"Sensing centromere tension: Aurora B and the regulation of kinetochore function","volume":"21","author":"Lampson","year":"2011","journal-title":"Trends Cell Biol"},{"issue":"7","key":"10.1016\/j.leukres.2012.10.017_bib0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bcp.2011.01.017","article-title":"Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma","volume":"81","author":"Qi","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.leukres.2012.10.017_bib0055","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI59954","article-title":"Chromosomal instability and cancer: a complex relationship with therapeutic potential","volume":"122","author":"Bakhoum","year":"2012","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.leukres.2012.10.017_bib0060","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/labinvest.2009.106","article-title":"Analysis of Aurora B kinase in non-Hodgkin lymphoma","volume":"89","author":"Ikezoe","year":"2009","journal-title":"Lab Invest"},{"issue":"12","key":"10.1016\/j.leukres.2012.10.017_bib0065","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-05-0146","article-title":"Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures","volume":"4","author":"Mahadevan","year":"2005","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.leukres.2012.10.017_bib0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic \u03b3\u03b4 T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2012.10.017_bib0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1349-7006.2010.01499.x","article-title":"A selective inhibitor MLN8237 suppresses the growth and survival of HTLV-1-infected T-cells in vitro","volume":"101","author":"Tomita","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.leukres.2012.10.017_bib0080","series-title":"American Society of Hematology, #95, 53rd Annual Meeting","article-title":"Phase 2 trial of Alisertib (MLN8237), an investigational, potent inhibitor of aurora A kinase (AAK), in patients (pts) with aggressive B- and T-cell non-Hodgkin lymphoma (NHL)","author":"Friedberg","year":"2011"},{"key":"10.1016\/j.leukres.2012.10.017_bib0085","article-title":"Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350","volume":"July 25","author":"Mahadevan","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2012.10.017_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharma.2008.12.005","article-title":"Inhibitors of aurora kinases","volume":"67","author":"Pinel","year":"2009","journal-title":"Ann Pharm Fr"},{"issue":"7","key":"10.1016\/j.leukres.2012.10.017_bib0095","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/0008-5472.CAN-04-3981","article-title":"RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells","volume":"65","author":"Hata","year":"2005","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.leukres.2012.10.017_bib0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0092-8674(03)00642-1","article-title":"Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells","volume":"114","author":"Hirota","year":"2003","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.leukres.2012.10.017_bib0105","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1073\/pnas.0601425103","article-title":"Aurora A, mitotic entry, and spindle bipolarity","volume":"103","author":"Liu","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.leukres.2012.10.017_bib0110","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1365-2443.2002.00592.x","article-title":"Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells","volume":"7","author":"Marumoto","year":"2002","journal-title":"Genes Cells"},{"issue":"2","key":"10.1016\/j.leukres.2012.10.017_bib0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.200208091","article-title":"Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores","volume":"161","author":"Ditchfield","year":"2003","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.leukres.2012.10.017_bib0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.200208092","article-title":"The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint","volume":"161","author":"Hauf","year":"2003","journal-title":"J Cell Biol"},{"issue":"8","key":"10.1016\/j.leukres.2012.10.017_bib0125","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1091\/mbc.E02-11-0769","article-title":"Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis","volume":"14","author":"Honda","year":"2003","journal-title":"Mol Biol Cell"},{"issue":"11","key":"10.1016\/j.leukres.2012.10.017_bib0130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0960-9822(02)00848-5","article-title":"The kinase activity of aurora B is required for kinetochore\u2013microtubule interactions during mitosis","volume":"12","author":"Murata-Hori","year":"2002","journal-title":"Curr Biol"},{"issue":"8","key":"10.1016\/j.leukres.2012.10.017_bib0135","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1158\/1078-0432.CCR-11-2413","article-title":"Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma","volume":"18","author":"Mahadevan","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612004298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612004298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T13:23:29Z","timestamp":1540128209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612004298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0145212612004298"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.10.017","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}